Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shukra Pharmaceuticals Limited (NSE: SHUKRAPHAR), ISIN INE551C01044 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHUKRAPHAR last traded at ₹82.00 (+2.65%), with a 52-week range of ₹40.06 to ₹84.50 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.15%, FIIs 0.43%, DIIs 0.21%, mutual funds 0.00%.
EquiSense Score (ECS): 41/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.